drugset / Trial / NCT04705909

Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer

NCT04705909

Phase 2/3 Unknown 60 enrolled Mansoura University
RandomizedParallel-groupSingle-blindTreatment

Summary

Different modalities for breast cancer treatments have exhausting and distressing side effects and toxicities leading to decreased compliance. Thus, repurposing drugs with accepted safety profile and possible antitumor activity becomes an eminent constraint. Statins have been reported to have possible advantages as anticancer, and control of cancer progression. Moreover, they can sensitize cancer cells for radiotherapy. Therefore, the investigators aim to investigate the effect of (pitavastatin) added to conventional chemotherapy protocols for breast cancer patients.

Timeline

Start
2021-01-15
Primary completion
2021-09-15
Completion
2021-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Pitavastatin Small molecule 2 mg Oral

Indications